IRCT2016100430130N1已完成未知
The effect of intravitreal adalimumab injection on pseudophakic macular edema
Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 85 years（—）
- 性别
- All
入选标准
- •patients with pseudophakic macular edema and PCIOL in bag who have received prior treatment (topical NSAIDs or topical corticosteroids). Exclusion criteria: patients with macular edema due to causes other than pseudophakia(diabetes, uveitis, retinitis pigmentosa); complicated surgery (vitrous loss); PCIOL in sulcus and ACIOL.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of diclofenac eye drop and Bevacizumab and Triamcinolone in preventing part of the retina edemaDiabetic retinopathyDiabetic retinopathy.IRCT2017050833875N1Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences45
进行中（未招募）
不适用
Silmän sisäisten lääkeainepistosten aikaan saama hermoston uudelleen muokaantuvuusEUCTR2012-000765-20-FIKuopion yliopistollinen sairaala/silmätautien poliklinikka
尚未招募
2 期
The effect of Adalimumab in the treatment of patients with chronic schizophreniaSchizophrenia.SchizophreniaIRCT20090117001556N126Tehran University of Medical Sciences50
招募中
3 期
Adalimumab effect on COVID-19IRCT20171105037262N4Bagheiat-allah University of Medical Sciences100
已完成
3 期
The efficacy of intravitreal aflibercept given in a ‘treat and extend’ regime in the treatment of cystoid macular oedema secondary to central retinal vein occlusion.central retinal vein occlusion (CRVO).cystoid macular oedemaEye - Diseases / disorders of the eyeACTRN12615000417583Centre for Eye Research Australia20